Literature DB >> 22522392

The use of a supplemental sulcus fixated IOL (HumanOptics Add-On IOL) to correct pseudophakic refractive errors.

Berna Basarir1, Vedat Kaya, Cigdem Altan, Sezen Karakus, Eylem Y Pinarci, Ahmet Demirok.   

Abstract

PURPOSE: To evaluate the safety and efficacy of piggybacking with the HumanOptics Add-On intraocular lens (IOL) to correct pseudophakic refractive errors.
MATERIALS AND METHODS: Ten eyes of 10 patients with pseudophakic refractive errors were included in this study. All patients were targeted for a range of refraction -0.50 to +0.50 D. Uncorrected and corrected distance visual acuities (UDVA and CDVA, respectively), endothelial cell count (ECC), anterior chamber depth (ACD), the distance between intraocular lenses, and contrast sensitivity measurements under mesopic, scotopic, and scotopic with glare conditions were evaluated preoperatively and postoperatively.
RESULTS: The mean age of the patients was 54±27 years (range 4-78). Mean follow-up time was 10.5±1.36 months (range 6-15 months). Mean diopters of implanted Add-On IOLs were -1.4±6.9 (range -12 to +9 D). Mean preoperative and postoperative UDVA was 0.133±0.12 and 0.73±0.27, respectively (p=0.0001); mean preoperative and postoperative CDVA were 0.77±0.26 and 0.79±0.27, respectively (p=0.066). Mean preoperative and postoperative ACD were 3.87±0.91 mm vs 3.58±1.05 mm, respectively (p=0.343); mean inter-IOL distance was 0.53±0.08 mm. Mean preoperative and postoperative ECC were 2455±302 and 2426±294, respectively (p=0.55). All patients were within the targeted refractive range of -0.50 D to +0.50 D. No complications were observed during the operations or postoperative follow-up period.
CONCLUSIONS: Piggybacking with the Add-On IOL is a safe, efficient, and reliable technique to correct pseudophakic refractive errors.

Entities:  

Mesh:

Year:  2012        PMID: 22522392     DOI: 10.5301/ejo.5000156

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  8 in total

1.  Assessment of a new hydrophilic acrylic supplementary IOL for sulcus fixation in pseudophakic cadaver eyes.

Authors:  N Reiter; L Werner; J Guan; J Li; K T Tsaousis; N Mamalis; S Srinivasan
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

2.  Reversibility of the duet procedure: Bilateral exchange of a supplementary trifocal sulcus-fixated intraocular lens for correction of a postoperative refractive error.

Authors:  Isabella Diana Baur; Gerd Uwe Auffarth; Timur Mert Yildirim; Christian Steffen Mayer; Ramin Khoramnia
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-10

3.  A pinhole implant to correct postoperative residual refractive error in an RK cataract patient.

Authors:  Hyeck-Soo Son; Ramin Khoramnia; Christian Mayer; Grzegorz Labuz; Timur M Yildirim; Gerd U Auffarth
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-20

4.  Secondary Piggyback Intraocular Lens for Management of Residual Ametropia after Cataract Surgery.

Authors:  Zahra Karjou; Mohammad-Reza Jafarinasab; Mohammad-Hassan Seifi; Kiana Hassanpour; Bahareh Kheiri
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20

5.  Monofocal intraocular lens with enhanced intermediate function as substitute for multifocal intraocular lens in positive dysphotopsia.

Authors:  Tadas Naujokaitis; Ling Zhao; Debora Scharf; Ramin Khoramnia; Gerd U Auffarth
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

6.  Spectacle Independence for Pseudophakic Patients - Experience with a Trifocal Supplementary Add-on Intraocular Lens.

Authors:  Carlos Palomino-Bautista; Rubén Sánchez-Jean; David Carmona Gonzalez; Marta Romero Domínguez; Alfredo Castillo Gómez
Journal:  Clin Ophthalmol       Date:  2020-04-09

Review 7.  Surgical options for correction of refractive error following cataract surgery.

Authors:  Ahmed A Abdelghany; Jorge L Alio
Journal:  Eye Vis (Lond)       Date:  2014-10-16

8.  Enhancement-procedure outcomes in patients implanted with the Precisight multicomponent intraocular lens.

Authors:  Harvey S Uy; Carolina Tesone-Coelho; Harilaos Ginis
Journal:  Clin Ophthalmol       Date:  2019-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.